Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recessive Dystrophic Epidermolysis Bullosa (RDEB)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Large-scale testing (Phase 3)Study completedNCT04917874
What this trial is testing

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis BullosaDEB - Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa+1 more
Krystal Biotech, Inc. 47
Not applicableStudy completedNCT00904163
What this trial is testing

Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica
Stanford University 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04186650
What this trial is testing

Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts

Who this might be right for
Epidermolysis Bullosa Dystrophica, Recessive
Institut National de la Santé Et de la Recherche Médicale, France 3
Testing effectiveness (Phase 2)Study completedNCT05143190
What this trial is testing

Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Phoenix Tissue Repair, Inc. 2
Large-scale testing (Phase 3)Study completedNCT04491604
What this trial is testing

Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB

Who this might be right for
Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis BullosaDominant Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc. 31
Testing effectiveness (Phase 2)Looking for participantsNCT07193134
What this trial is testing

GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment

Who this might be right for
RDEBRecessive Dystrophic Epidermolysis BullosaEpidermolysis Bullosa Dystrophica, Recessive
CHU de Quebec-Universite Laval 9
Not applicableActive Not RecruitingNCT05843994
What this trial is testing

Artificial Intelligence Patient App for RDEB SCCs

Who this might be right for
Epidermolysis Bullosa Dystrophica
Northwestern University 20
Testing effectiveness (Phase 2)Study completedNCT03012191
What this trial is testing

Gentamicin for RDEB

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
University of Southern California 6
Early research (Phase 1)Study completedNCT02493816
What this trial is testing

Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
King's College London 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07011589
What this trial is testing

Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa AcquisitaRecessive Dystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich 18